泽纳斯生物制药 ZBIO
$28.26 +$2.33 (+8.99%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $28.26 0.00%
开盘$26.21
昨收$25.93
当日区间$25.83 – $28.44
成交量544.0K
市值$1.92B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$1.00M
营业利润-$77.66M-40.8% YoY
净利润-$111.46M-113.4% YoY
摊薄每股收益-$1.77-41.6% YoY
自由现金流-$87.24M-109.0% YoY
经营现金流-$57.24M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
营业利润率-27,390.1%
净利率-48,438.4%
净资产收益率-199.0%
资产收益率-97.4%
投入资本回报率-122.0%
流动比率9.93
负债/资产比率64.8%
现金及投资$643.13M
总负债$297.04M
净现金（净负债）$346.09M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $1.00M | $0.00 | $10.00M | $0.00 | $0.00 |
| 营业总收入 | $1.00M | $0.00 | $10.00M | $0.00 | $0.00 |
| 营业费用 | $78.66M | $77.35M | $221.39M | $71.31M | $47.58M |
| 销售及管理费用 | $15.75M | $16.91M | $53.32M | $15.59M | $13.18M |
| -管理费用 | $15.75M | $16.91M | $53.32M | $15.59M | $13.18M |
| 研发费用 | $62.91M | $60.44M | $168.06M | $55.72M | $34.40M |
| 营业利润 | -$77.66M | -$77.35M | -$211.39M | -$71.31M | -$47.58M |
| 非经营性利息净收入（支出） | -$3.70M | -$3.61M | $4.82M | – | – |
| 非经营性利息收入 | $6.60M | $3.02M | $12.15M | – | – |
| 非经营性利息支出 | $10.30M | $6.63M | $7.33M | – | – |
| 其他收入（支出） | -$29.98M | -$24,000.00 | -$171.26M | -$173.85M | -$3.92M |
| 特殊收益（费用） | -$30.00M | – | -$171.67M | -$166.67M | -$5.00M |
| -减：其他特殊支出 | $30.00M | – | $171.67M | $166.67M | $5.00M |
| 其他非经营性收入（支出） | $16,000.00 | -$24,000.00 | $417,000.00 | -$7.18M | $1.08M |
| 税前利润 | -$111.34M | -$80.99M | -$377.82M | -$240.34M | -$51.50M |
| 税费 | $114,000.00 | $0.00 | -$79,000.00 | $106,000.00 | $0.00 |
| 净利润 | -$111.46M | -$80.99M | -$377.74M | -$240.44M | -$51.50M |
| 持续经营利润 | -$111.46M | -$80.99M | -$377.74M | -$240.44M | -$51.50M |
| 归属母公司净利润 | -$111.46M | -$80.99M | -$377.74M | -$240.44M | -$51.50M |
| 归属普通股股东净利润 | -$111.46M | -$80.99M | -$377.74M | -$240.44M | -$51.50M |
| 基本每股收益 | -$1.77 | -$1.46 | -$8.44 | -$4.54 | -$1.22 |
| 摊薄每股收益 | -$1.77 | -$1.46 | -$8.44 | -$4.54 | -$1.22 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $701.69M | $747.68M | $383.64M | $383.64M | $322.02M |
| 流动资产合计 | $653.79M | $730.16M | $351.17M | $351.17M | $296.64M |
| 现金及现金等价物与短期投资 | $643.13M | $717.21M | $343.19M | $343.19M | $290.88M |
| -现金及现金等价物 | $196.58M | $500.22M | $110.64M | $110.64M | $115.57M |
| -短期投资 | $446.55M | $216.98M | $232.55M | $232.55M | $175.32M |
| 其他流动资产 | $10.67M | $12.96M | $7.98M | $7.98M | $5.76M |
| 非流动资产合计 | $47.90M | $17.52M | $32.47M | $32.47M | $25.38M |
| 固定资产净值 | $844,000.00 | $1.12M | $1.39M | $1.39M | $857,000.00 |
| -固定资产原值 | $844,000.00 | $1.12M | $1.39M | $1.39M | $857,000.00 |
| 投资及预付款 | $30.76M | $1.34M | $17.27M | $17.27M | $10.72M |
| 一年以上预付资产 | $15.72M | $14.54M | $12.88M | $12.88M | $12.88M |
| 一年以上递延资产 | $486,000.00 | $439,000.00 | $709,000.00 | $709,000.00 | $837,000.00 |
| 其他非流动资产 | $87,000.00 | $86,000.00 | $218,000.00 | $218,000.00 | $83,000.00 |
| 负债合计 | $454.59M | $411.85M | $141.50M | $141.50M | $125.59M |
| 流动负债合计 | $65.82M | $61.16M | $62.65M | $62.65M | $52.42M |
| 应付款 | $7.59M | $9.06M | $7.23M | $7.23M | $6.44M |
| -应付账款 | $7.59M | $8.94M | $7.11M | $7.11M | $6.44M |
| -应付税款合计 | $0.00 | $118,000.00 | $118,000.00 | $118,000.00 | $0.00 |
| 一年内应计费用 | $47.57M | $45.44M | $41.23M | $41.23M | $36.60M |
| 短期债务及融资租赁负债 | $823,000.00 | $1.04M | $1.12M | $1.12M | $618,000.00 |
| -一年内到期融资租赁负债 | $823,000.00 | $1.04M | $1.12M | $1.12M | $618,000.00 |
| 非流动负债合计 | $388.78M | $350.69M | $78.85M | $78.85M | $73.17M |
| 长期债务及融资租赁负债 | $297.04M | $265.79M | $211,000.00 | $211,000.00 | $180,000.00 |
| -长期债务 | $297.02M | $265.72M | – | – | – |
| -长期融资租赁负债 | $22,000.00 | $77,000.00 | $211,000.00 | $211,000.00 | $180,000.00 |
| 其他非流动负债 | $91.74M | $84.90M | $78.64M | $78.64M | $72.99M |
| 股东权益合计 | $247.10M | $335.83M | $242.14M | $242.14M | $196.43M |
| 股东权益 | $247.10M | $335.83M | $242.14M | $242.14M | $196.43M |
| 股本 | $6,000.00 | $6,000.00 | $5,000.00 | $5,000.00 | $4,000.00 |
| -普通股 | $6,000.00 | $6,000.00 | $5,000.00 | $5,000.00 | $4,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $1.21B | $1.18B | $1.01B | $1.01B | $721.18M |
| 留存收益 | -$957.57M | -$846.12M | -$765.13M | -$765.13M | -$524.69M |
| 不影响留存收益的损益 | -$1.14M | -$377,000.00 | -$64,000.00 | -$64,000.00 | -$69,000.00 |
| 受限现金 | – | – | $0.00 | $0.00 | $0.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$57.24M | -$75.20M | -$172.33M | -$52.41M | -$41.13M |
| 持续经营经营活动现金流净额 | -$57.24M | -$75.20M | -$172.33M | -$52.41M | -$41.13M |
| 持续经营净利润 | -$111.46M | -$80.99M | -$377.74M | -$240.44M | -$51.50M |
| 折旧、折耗与摊销 | $4,000.00 | $6,000.00 | $56,000.00 | $10,000.00 | $11,000.00 |
| 其他非现金项目 | $39.44M | $6.56M | $179.87M | $172.54M | $6.88M |
| 营运资金变动 | $7.44M | -$9.86M | $951,000.00 | $8.32M | -$3.66M |
| -预付资产变动 | $1.11M | -$6.48M | -$3.16M | -$2.36M | -$1.60M |
| -应付账款及应计费用变动 | $6.60M | -$3.17M | $5.01M | $10.92M | -$1.85M |
| -其他流动负债变动 | -$270,000.00 | -$211,000.00 | -$902,000.00 | -$245,000.00 | -$211,000.00 |
| 投资活动现金流净额 | -$287.70M | $31.61M | -$251.89M | -$93.36M | $40.04M |
| 持续经营投资活动现金流净额 | -$287.70M | $31.61M | -$251.89M | -$93.36M | $40.04M |
| 固定资产购置及出售净额 | $0.00 | -$2,000.00 | -$18,000.00 | $0.00 | $0.00 |
| 投资购置及出售净额 | -$257.70M | $31.61M | -$216.87M | -$63.36M | $45.04M |
| 筹资活动现金流 | $42.06M | $433.48M | $215.28M | $140.84M | $72.62M |
| 持续经营筹资活动现金流净额 | $42.06M | $433.48M | $215.28M | $140.84M | $72.62M |
| 债务发行及偿还净额 | $29.10M | $267.50M | – | – | $75.00M |
| 普通股发行净额 | $14.10M | $165.53M | $148.57M | $148.57M | $0.00 |
| 股票期权行使所得 | $806,000.00 | $959,000.00 | $4.37M | $1.61M | $940,000.00 |
| 其他筹资费用净额 | -$1.95M | -$512,000.00 | $62.34M | $65.66M | – |
| 期末现金余额 | $196.58M | $500.22M | $110.64M | $110.64M | $115.57M |
| 现金净变动 | -$302.88M | $389.89M | -$208.94M | -$4.94M | $71.53M |
| 期初现金余额 | $500.22M | $110.64M | $319.83M | $115.57M | $44.01M |
| 汇率变动影响 | -$763,000.00 | -$311,000.00 | -$252,000.00 | $11,000.00 | $25,000.00 |
| 自由现金流 | -$87.24M | -$75.20M | -$207.35M | -$82.41M | -$46.13M |
| 持续经营损益 | – | – | $107,000.00 | $0.00 | $0.00 |
| 无形资产购置及出售净额 | – | – | -$35.00M | -$30.00M | -$5.00M |
| 优先股发行净额 | – | – | $0.00 | $0.00 | – |
暂无评论——快来第一个聊聊 ZBIO。
登录后参与讨论。